Stay updated on iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the study page, signaling a new version of the record. This is a metadata change and does not alter the study’s content.
    Difference
    0.1%
    Check dated 2026-05-18T03:43:53.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision label at the bottom changes from v3.5.2 to v3.5.3, indicating a minor site release update without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-26T08:24:00.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.2 and remove v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T01:38:20.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Updated the page’s revision tag from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:48:46.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T20:39:33.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No user-facing content or study information appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:17:59.000Z thumbnail image

Stay in the know with updates to iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.